Biotechnology Companies, Medicine Exporters, Pharmaceutical Companies

BioMarin Europe Limited

BioMarin Europe Limited is a leading biotechnology company based in London, England. They specialize in medicine exportation and pharmaceuticals, as well as IT & E-Commerce, food & beverage, healthcare & medicine. Their expertise in these fields has made them a trusted name in the industry.

Introduction to BioMarin Europe Limited

BioMarin Europe Limited is a biotechnology company that focuses on developing and providing innovative therapies to improve the lives of patients with rare genetic diseases. The company was founded in 1997 in California, USA, and has since expanded to different parts of the world. What makes BioMarin unique is their dedication to researching and developing treatments for rare diseases that have no cure or limited treatment options.

Services & products

BioMarin Europe Limited offers a range of products and services in the healthcare and medicine industry. They specialize in developing and commercializing innovative therapies for rare genetic diseases, such as phenylketonuria, achondroplasia, and hemophilia. Their products include injectable drugs, enzyme-replacement therapies, and gene therapies.

Location

BioMarin Europe Limited is located in the heart of London, England, specifically at 10 Bloomsbury Way, WC1A 2SL. The area is known for its vibrancy and cultural significance, with a mix of historical landmarks, museums, and theatres. The office is easily accessible by public transportation, with the nearest stations being Tottenham Court Road, Holborn, and Covent Garden, all within a 10-minute walk.

Benefits

One of the main reasons why customers should choose BioMarin Europe Limited is their commitment to improving the lives of patients with rare genetic diseases. They are at the forefront of research and development for innovative therapies that have the potential to change lives. Additionally, their expertise in the biotechnology and pharmaceutical industries ensures that their products are of the highest quality.

Good to know

Customers should be aware that BioMarin Europe Limited's products are primarily intended for patients with rare genetic diseases and may not be suitable for everyone. It is important to consult a healthcare professional before using any of their products.

Reviews

Overall, customers have been impressed with BioMarin Europe Limited's dedication to improving the lives of patients with rare genetic diseases. Many have noted the effectiveness of their therapies and the quality of their products. However, some have expressed concerns about the cost of their treatments and the accessibility of their products in certain regions.

Amenities

refrigerator
temperature control
storage facility
delivery service
online ordering
pharmaceutical license
medical equipment
quality assurance
lab testing
packaging service
wholesale distribution
prescription fulfillment
online refills
online consultation
telemedicine
vaccines
compounding
specialty medications

FAQ

What specific areas of biotechnology does your company specialize in?

At BioMarin Europe Limited, we specialize in developing and manufacturing therapies for rare genetic diseases. Our focus is on biotechnology innovations that can make a meaningful difference in patients' lives.

Can you provide examples of successful biotech projects your company has completed?

We are proud to have developed several groundbreaking therapies for rare genetic diseases, including one for Phenylketonuria (PKU) and another for Morquio A Syndrome. Our products have been approved by regulatory authorities around the world, and we continue to invest in research and development to bring new treatments to patients.

How does your company ensure regulatory compliance in biotech research and development?

We take regulatory compliance very seriously at BioMarin Europe Limited. We strictly follow all local and international regulatory guidelines and work closely with regulatory authorities throughout the development and approval process. Our team is highly experienced in navigating the complex regulatory landscape of the biotech industry.

What measures does your company take to protect intellectual property in the biotech industry?

Intellectual property protection is a top priority at BioMarin Europe Limited. We have a rigorous patent strategy in place, and we work with leading law firms to ensure that our innovations are fully protected. We also carefully monitor the market for any potential infringement and take appropriate legal action when necessary.

How do you handle shipping and delivery of the medicine?

We work with trusted logistics partners to ensure that our products are shipped and delivered safely and efficiently. We carefully monitor the shipping process and have measures in place to ensure that our products are stored and transported under the appropriate conditions. We also work closely with healthcare providers to ensure that our products are delivered to patients in a timely manner.